Skip to main content

Journey Medical Corp(DERM-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference

Globe Newswire - Mon May 23, 2022

SCOTTSDALE, Ariz., May 23, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM), a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions, today announced that management will present at the B. Riley Securities 22nd Annual Institutional Investor Conference, which is being held May 25-26, 2022 in Beverly Hills, California.

Read more at globenewswire.com

Provided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe